Effects of a randomized comprehensive psychosocial intervention based on cognitive behavioral therapy theory and motivational interviewing techniques for community rehabilitation of patients with opioid use disorders in Shanghai, China

Journal of Addiction Medicine

Volumn 9, Issue 4, 2015, Pages 322-330

  Zhong, Na ^a   Yuan, Ying ^b   Chen, Hanhui ^a   Jiang, Haifeng ^a   Du, Jiang ^a   Sun, Haiming ^a   Hao, Wei ^c   Zhao, Min ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Suzhou Guangji Hospital   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Cognitive behavioral therapy; Community rehabilitation; Comprehensive psychosocial intervention; Heroin dependence; Motivational interviewing

Indexed keywords

AMPHETAMINE;

ADDICTION SEVERITY INDEX; ADULT; ANXIETY; ARTICLE; CHINA; CLINICAL EFFECTIVENESS; COGNITIVE THERAPY; COMMUNITY CARE; CONTROLLED STUDY; EMOTIONAL STABILITY; FEMALE; FOLLOW UP; HEROIN DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTIVATIONAL INTERVIEWING TECHNIQUE; OBSESSIVE COMPULSIVE DISORDER; OPIATE ADDICTION; PARANOIA; PHOBIA; PRIORITY JOURNAL; PSYCHOSIS; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RELAPSE; RISK FACTOR; RISK REDUCTION; SHORT FORM 36; SOMATIZATION; SYMPTOM CHECKLIST 90; TREATMENT DURATION; URINALYSIS; VALIDATION PROCESS; MIDDLE AGED; MOTIVATIONAL INTERVIEWING; OPIOID-RELATED DISORDERS; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PROCEDURES;

ADULT; CHINA; COGNITIVE THERAPY; COMMUNITY HEALTH SERVICES; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTIVATIONAL INTERVIEWING; OPIOID-RELATED DISORDERS; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE;

EID: 84942893014     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0000000000000139     Document Type: Article

References (40)

1. Amato L, Minozzi S, Davoli M, et al. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database Syst Rev 2008;4:CD004147.
2. Amato L, Minozzi S, Davoli M. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database Syst Rev 2011;10:CD004147.
3. Bellack AS, Bennett M, Gearon JS, et al. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness. Arch Gen Psychiatry 2006;63(4):426-432.
4. Castellani B, Wedgeworth R, Wootton E, et al. A bi-directional theory of addiction: examining coping and the factors related to substance relapse. Addict Behav 1997;22(1):139-144.
5. Chawarski MC, Zhou W, Schottenfeld RS. Behavioral drug and HIV risk reduction counseling (BDRC) in MMT programs in Wuhan, China: a pilot randomized clinical trial. Drug Alcohol Depend 2011;115(3):237-239.
6. Chen SL, Li LJ. Re-testing reliability, validity and norm applicability of SCL-90. Chin J Nerv Ment Dis 2003;29(5):323-327.
7. China National Narcotics Control Commission. Annual National Narcotic Control Report 2011. Beijing, China: Office of NNCC, 2011.
8. Deering D, Frampton C, Horn J, et al. Health status of clients receiving methadone maintenance treatment using the SF-36 health survey questionnaire. Drug Alcohol Rev 2004;23(3):273-280.
9. Dissabandara LO, Loxton NJ, Dias SR, et al. Dependent heroin use and associated risky behaviour: the role of rash impulsiveness and reward sensitivity. Addict Behav 2013;39:71-76. doi:10.1016/j.addbeh.2013.06.009.
10. Evans JL, Hahn JA, Lum PJ, et al. Predictors of injection drug use cessation and relapse in a prospective cohort of young injection drug users in San Francisco, CA (UFO Study). Drug Alcohol Depend 2009;101(3):152-157.
11. Holi M. Assessment of Psychiatric Symptoms Using the SCL-90. Helsinki: Helsinki University Printing House, 2003.
12. Hosmer DW, Lemeshow S. Applied Logistic Regression, 2nd edition. New York, NY: John Wiley and Sons, 2000.
13. Hser YI. Predicting long-term stable recovery from heroin addiction: findings from a 33-year follow-up study. J Addict Dis 2007;26(1):51-60.
14. Hser YI, Fu L, Wu F, et al. Pilot trial of a recovery management intervention for heroin addicts released from compulsory rehabilitation in China. J Subst Abuse Treament 2012;44:78-83. doi:10.1016/j.jsat.2012.03.009.
15. Iskandar S, Kamal R, De Jong CA. Psychiatric comorbidity in injecting drug users in Asia and Africa. Curr Opin Psychiatry 2012;25(3):213-218.
16. Kashner TM, Rosenheck R, Campinell AB, et al. Impact of work therapy on health status among homeless, substance-dependent veterans: a randomized controlled trial. Arch Gen Psychiatry 2002;59(10):938-944.
17. Khantzian EJ. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry 1997;4(5):231-244.
18. Ko NY, Wang P, Wu HC, et al. Self-efficacy and HIV risk behaviors among heroin users in Taiwan. J Stud Alcohol Drugs 2012;73(3):469-476.
19. Larimer ME, Palmer RS, Marlatt GA. Relapse prevention: an overview of Marlatt's cognitive-behavioral model. Alcohol Res Health 1999;23(2):151-160.
20. Lee KH, Bowen S, Oei TP, et al. An expanded self-medication hypothesis based on cognitive-behavioral determinants for heroin abusers in Taiwan: a cross-sectional study. Am J Addict 2012;21(Suppl 1):S43-S48.
21. Liao Y, Tang J, Liu T, et al. A pilot study of life events and mood disorders: self-report survey in Chinese heroin-dependent individuals. Am J Addict 2011;20(4):337-342.
22. Lin C, Wu Z, Detels R. Family support, qualityoflife and concurrent substance use among methadone maintenance therapy clients in China. Public Health 2011;125(5):269-274.
23. Liu XB, Li DJ, Zhang SM. Relationship between detoxification time and mental symptoms of heroin addicts. Chin J Drug Abuse Prevent Treatment 2006;12(4):200-202.
24. McLellan AT, Luborsky L, Woody GE, et al. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis 1980;168(1):26-33.
25. Miller WR, Rose GS. Toward a theory of motivational interviewing. Am Psychol 2009;64(6):527-537.
26. Miller WR, Yahne C, Tonigan JS. Motivational interviewing in drug abuse services: a randomized trial. J Consult Clin Psychol 2003;71(4):754-763.
27. Moser AE, Annis HM. The role of coping in relapse crisis outcome: a prospective study of treated alcoholics. Addiction 1996;91(8):1101-1113.
28. Preston KL, Epstein D. Stress in the daily lives of cocaine and heroin users: relationship to mood, craving, relapse triggers, and cocaine use. Psychopharmacology (Berl) 2011;218(1):29-37.
29. Ryan CF, White J. Health status at entry to methadone maintenance treatment using the SF-36 health survey questionnaire. Addiction 1996;91(1):39-45.
30. Siegal HA, Falck R, Wang J, et al. Predictors of drug abuse treatment entry among crack-cocaine smokers. Drug Alcohol Depend 2002;68(2):159-168.
31. te Vaarwerk MJ, Gaal E. Psychological distress and quality of life in drugusing and non-drug-using HIV-infected women. Eur J Public Health 2001;11(1):109-115.
32. Wang PW, Wu HC, Yen CN, et al. Change in quality of life and its predictors in heroin users receiving methadone maintenance treatment in Taiwan: an 18-month follow-up study. Am J Drug Alcohol Abuse 2012;38(3):213-219.
33. Wang QL, Liu Z. Characteristics of psychopathology and the relationship between routes of drug administration and psychiatric symptoms in heroin addicts. Subst Abuse 2012;33(2):130-137.
34. Wang ZW. The self-report symptom check-list 90 (SCL-90). Shanghai Arch Psychiatry 1984;2:68-70.
35. Watkins KE, Hunter S, Hepner KA, et al. An effectiveness trial of group cognitive behavioral therapy for patients with persistent depressive symptoms in substance abuse treatment. Arch Gen Psychiatry 2011;68(6):577-584.
36. Woody GE, Luborsky L, McLellan AT, et al. Psychotherapy for opiate addicts. Does it help? Arch Gen Psychiatry 1983;40(6):639-645.
37. Woody GE, McLellan AT, Luborsky L, et al. Psychotherapy in community methadone programs: a validation study. Am J Psychiatry 1995;152(9):1302-1308.
38. Yan S, Lian Z, Sun G, et al. Assessment of the Chinese-version SF-36 in the Chinese opiate addicts. Subst Use Misuse 2011;46(13):1561-1568.
39. Zhao M, Li X, Hao W, et al. A preliminary study of the reliability and validity of the Addiction Severity Index in Chinese drug use population. J Chin Med Res 2004;4(8):679-680.
40. Zhuang X, Liang Y, Chow EP, et al. HIV and HCV prevalence among entrants to methadone maintenance treatment clinics in China: a systematic review and meta-analysis. BMC Infect Dis 2012;12:130. doi:10.1186/1471-2334-12-130.